Reuters logo
BRIEF-Oncurious acquires unique portfolio of immuno-oncology assets from VIB
September 1, 2017 / 5:40 AM / 2 months ago

BRIEF-Oncurious acquires unique portfolio of immuno-oncology assets from VIB

Sept 1 (Reuters) - THROMBOGENICS NV:

* ONCURIOUS NV ACQUIRES UNIQUE PORTFOLIO OF NEXT-GENERATION IMMUNO-ONCOLOGY ASSETS FROM VIB

* ONCURIOUS - ‍VIB WILL INCREASE ITS STAKE IN ONCURIOUS, WITH THROMBOGENICS REMAINING MAJORITY SHAREHOLDER​

* ONCURIOUS - ‍VIB WILL ALSO RECEIVE A ROYALTY ON FUTURE SALES OF ANY OF THESE ASSETS​

* ONCURIOUS NV - THROMBOGENICS INVESTS AN ADDITIONAL EUR 2.1 MILLION IN ONCURIOUS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below